Variants in the glycosyltransferase domain of ALG13, particularly c.320A>G, p.N107S, lead to ALG13-CDG, a severe disorder of glycosylation with predominantly neurological manifestations, including developmental delay, intellectual disability, seizures, and central hypotonia [3,4,5,6,7,8]. This evidence concerns the gene ALG13 and Intellectual disability.